Nasdaq

Masimo : FDA Oks Pediatric Indication For SedLine Brain Function Monitoring And EEG Sensor

(RTTNews) - Masimo (MASI) said that the U.S. FDA has cleared SedLine brain function monitoring for pediatric patients (1-17 years of age) and the SedLine Pediatric EEG Sensor. With this clearance, the ...
Nasdaq

Masimo's (MASI) SedLine Receives FDA's Pediatric Indication

Masimo Corporation MASI recently received the FDA’s clearance for SedLine brain function monitoring for pediatric patients (1-17 years of age) and the SedLine Pediatric EEG (electroencephalogram) ...
FierceBiotech

Masimo's brain-monitoring headset nabs FDA nod for use in kids

Masimo has made a name for itself as a prolific purveyor of noninvasive patient monitoring technologies, from the SET pulse oximeter to the recently CE-marked Rainbow SuperSensor, which continuously ...
Business Wire

Masimo Announces CE Marking of Pediatric Indication for Next Generation SedLine ® Brain Function Monitoring

NEUCHATEL, Switzerland--(BUSINESS WIRE)--Masimo (NASDAQ: MASI) announced today the CE marking of Next Generation SedLine ® brain function monitoring for pediatric patients (1-18 years of age). With ...